These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 9477132)
21. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease. Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996. van Spronsen DJ; Janssen-Heijnen ML; Breed WP; Coebergh JW Ann Hematol; 1999 Jul; 78(7):315-9. PubMed ID: 10466443 [TBL] [Abstract][Full Text] [Related]
23. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829 [TBL] [Abstract][Full Text] [Related]
24. Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE). Rudant J; Menegaux F; Leverger G; Baruchel A; Nelken B; Bertrand Y; Hartmann O; Pacquement H; Vérité C; Robert A; Michel G; Margueritte G; Gandemer V; Hémon D; Clavel J Int J Cancer; 2007 Jul; 121(1):119-26. PubMed ID: 17330239 [TBL] [Abstract][Full Text] [Related]
25. The influence of parental age and gender on anticipation in familial B-cell malignancies. Alexandrescu DT; Wiernik PH Med Oncol; 2007; 24(1):55-62. PubMed ID: 17673812 [TBL] [Abstract][Full Text] [Related]
26. Incidence of non-Hodgkin's lymphoma in patients treated for Hodgkin's disease. Prósper F; Robledo C; Cuesta B; Rifón J; Borbolla JR; Pardo J; Rocha E Leuk Lymphoma; 1994 Feb; 12(5-6):457-62. PubMed ID: 8180608 [TBL] [Abstract][Full Text] [Related]
28. Familial Hodgkin's lymphoma in Scandinavia. Jønsson V; Awan H; Nyquist E; Maisenhølder M; Johannesen TB; Ly B; Tjønnfjord GE In Vivo; 2011; 25(3):431-7. PubMed ID: 21576419 [TBL] [Abstract][Full Text] [Related]
29. Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC Ann Oncol; 1997; 8 Suppl 2():59-63. PubMed ID: 9209643 [TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphoma of the brain after Hodgkin's disease. An immunohistochemical study. Davenport RD; O'Donnell LR; Schnitzer B; McKeever PE Cancer; 1991 Jan; 67(2):440-3. PubMed ID: 1985737 [TBL] [Abstract][Full Text] [Related]
31. Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma. Wiernik PH; Wang SQ; Hu XP; Marino P; Paietta E Br J Haematol; 2000 Jan; 108(1):72-9. PubMed ID: 10651726 [TBL] [Abstract][Full Text] [Related]
32. Association of endometriosis with family history of non-Hodgkin's lymphoma: presentation of 10 cases. Matalliotakis I; Cakmak H; Fragouli Y; Zervoudis S; Neonaki M; Arici A J BUON; 2009; 14(4):699-701. PubMed ID: 20148465 [TBL] [Abstract][Full Text] [Related]
33. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912. Kobrinsky NL; Sposto R; Shah NR; Anderson JR; DeLaat C; Morse M; Warkentin P; Gilchrist GS; Cohen MD; Shina D; Meadows AT J Clin Oncol; 2001 May; 19(9):2390-6. PubMed ID: 11331317 [TBL] [Abstract][Full Text] [Related]
34. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma. Kewalramani T; Nimer SD; Zelenetz AD; Malhotra S; Qin J; Yahalom J; Moskowitz CH Bone Marrow Transplant; 2003 Oct; 32(7):673-9. PubMed ID: 13130314 [TBL] [Abstract][Full Text] [Related]
35. Mortality from Hodgkin's disease and other lymphomas in Europe, 1960-1990. Levi F; La Vecchia C; Lucchini F; Te VC; Franceschi S Oncology; 1995; 52(2):93-6. PubMed ID: 7854782 [TBL] [Abstract][Full Text] [Related]
36. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease. Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391 [TBL] [Abstract][Full Text] [Related]
37. Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease. Silver RT; Case DC; Wheeler RH; Miller TP; Stein RS; Stuart JJ; Peterson BA; Rivkin SE; Golomb HM; Costanzi J Clin Oncol; 1991 May; 9(5):754-61. PubMed ID: 2016617 [TBL] [Abstract][Full Text] [Related]
38. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment. Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869 [TBL] [Abstract][Full Text] [Related]
39. Lymphoma cases referred to the radiation oncology service of a tertiary referral university hospital in Karachi, Pakistan: a retrospective study. Abbasi AN; Zahid S; Karsan F; Ali N; Bhurgri Y Asian Pac J Cancer Prev; 2010; 11(1):107-10. PubMed ID: 20593938 [TBL] [Abstract][Full Text] [Related]
40. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]